SLC37A3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.021000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.480000E-01
Normal-vs-Stage2
4.650600E-01
Normal-vs-Stage3
8.781600E-01
Normal-vs-Stage4
5.933600E-01
Stage1-vs-Stage2
7.657600E-01
Stage1-vs-Stage3
7.440000E-01
Stage1-vs-Stage4
8.559600E-01
Stage2-vs-Stage3
5.346000E-01
Stage2-vs-Stage4
9.818200E-01
Stage3-vs-Stage4
7.142800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.219400E-01
Normal-vs-AfricanAmerican
5.572200E-01
Normal-vs-Asian
4.296800E-01
Caucasian-vs-AfricanAmerican
8.925200E-01
Caucasian-vs-Asian
8.257200E-01
AfricanAmerican-vs-Asian
7.788400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.529800E-01
Normal-vs-Female
3.953600E-01
Male-vs-Female
9.380600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.507400E-01
Normal-vs-Age(41-60Yrs)
2.122600E-01
Normal-vs-Age(61-80Yrs)
6.832600E-01
Normal-vs-Age(81-100Yrs)
5.186000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.719000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.435000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.422200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.720300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.656030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.505400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.979800E-01
Normal-vs-Daily Drinker
7.342800E-01
Normal-vs-Weekly Drinker
3.974600E-01
Normal-vs-Occasional Drinker
5.014000E-01
Normal-vs-Social Drinker
1.804780E-01
Non Drinker-vs-Daily Drinker
6.434800E-01
Non Drinker-vs-Weekly Drinker
3.528000E-01
Non Drinker-vs-Occasional Drinker
7.010000E-01
Non Drinker-vs-Social Drinker
1.945620E-01
Daily Drinker-vs-Weekly Drinker
1.919760E-01
Daily Drinker-vs-Occasional Drinker
8.635600E-01
Daily Drinker-vs-Social Drinker
3.302100E-02
Weekly Drinker-vs-Occasional Drinker
1.999410E-01
Weekly Drinker-vs-Social Drinker
8.208200E-01
Occasional Drinker-vs-Social Drinker
3.662500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.967800E-01
Normal-vs-Grade 2
6.133800E-01
Normal-vs-Grade 3
1.765590E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.678200E-01
Grade 1-vs-Grade 3
3.488800E-01
Grade 1-vs-Grade 4
2.967800E-01
Grade 2-vs-Grade 3
9.131400E-01
Grade 2-vs-Grade 4
6.133800E-01
Grade 3-vs-Grade 4
1.765590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.609800E-01
Normal-vs-NonDiabetic
4.612200E-01
Diabetic-vs-NonDiabetic
2.418200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.439800E-01
Normal-vs-NoPancreatitis
6.131200E-01
Pancreatitis-vs-NoPancreatitis
7.880300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.733600E-01
Normal-vs-N1
4.666600E-01
N0-vs-N1
8.199800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.358200E-01
Normal-vs-TP53-NonMutant
4.663000E-01
TP53-Mutant-vs-TP53-NonMutant
2.296400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
